XML 120 R100.htm IDEA: XBRL DOCUMENT v3.22.2.2
INFORMATION ABOUT COMPONENTS OF EQUITY - Rizobacter Argentina and Insuagro (Details) - USD ($)
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Financial position        
Current assets $ 297,705,126 $ 211,489,658 $ 164,693,055  
Non-current assets 220,515,235 183,100,299 132,868,314  
Total assets. 518,220,361 394,589,957 297,561,369  
Current liabilities 222,665,752 168,037,855 130,610,709  
Non-current liabilities 137,255,761 136,261,798 106,201,178  
Total liabilities. 359,921,513 304,299,653 236,811,887  
Equity attributable to controlling interest 127,358,573 67,743,242 46,179,395  
Equity attributable to non-controlling interest 30,940,275 22,547,062 14,570,087  
Total equity 158,298,848 90,290,304 60,749,482 $ 62,094,866
Total liabilities and equity 518,220,361 394,589,957 297,561,369  
Summary statements of comprehensive income or loss        
Revenues 334,801,095 209,526,177 173,092,172  
Initial recognition and changes in the fair value of biological assets at the point of harvest 6,388,030 2,826,255 716,741  
Cost of sales (208,364,095) (118,641,803) (93,575,588)  
Gross Profit. 126,437,000 90,884,374 79,516,584  
Research and development expenses. (6,947,460) (5,617,655) (4,195,270)  
Selling, general and administrative (77,483,812) (47,601,901) (38,345,028)  
Share of profit or loss of joint ventures and associates 1,144,418 997,429 2,477,193  
Other income (3,280,220) (279,359) (307,499)  
Operating profit 39,869,926 38,382,888 39,145,980  
Financial results (25,806,296) (27,852,340) (32,702,642)  
Profit before income tax 14,063,630 10,530,548 6,443,338  
Income tax expense (17,972,534) (14,351,170) (2,206,710)  
Result for the year (3,908,904) (3,820,622) 4,236,628  
Foreign exchange differences on translation of foreign operations 32,635,104 10,076,208 (10,108,444)  
Revaluation of property, plant and equipment, net of tax 2 [1] (4,722,342) (2,268,839) 3,399,683  
Total comprehensive profit (loss) $ 31,263,346 $ 6,230,696 $ (5,445,488)  
Rizobacter Argentina        
Summarized financial information        
Proportion of ownership interests held by non-controlling interests 20.00% 20.00% 20.00%  
Financial position        
Current assets $ 294,372,669 $ 175,906,282 $ 148,256,827  
Non-current assets 77,663,085 59,860,206 49,843,457  
Total assets. 372,035,754 235,766,488 198,100,284  
Current liabilities 181,999,148 120,036,912 129,838,941  
Non-current liabilities 98,070,280 57,480,984 32,935,399  
Total liabilities. 280,069,428 177,517,896 162,774,340  
Equity attributable to controlling interest 91,965,153 58,246,057 35,324,227  
Equity attributable to non-controlling interest 1,173 2,535 1,717  
Total equity 91,966,326 58,248,592 35,325,944  
Total liabilities and equity 372,035,754 235,766,488 198,100,284  
Summary statements of comprehensive income or loss        
Revenues 280,625,028 189,749,478 162,404,866  
Initial recognition and changes in the fair value of biological assets at the point of harvest 3,973,780 1,552,746 716,741  
Cost of sales (176,497,573) (106,636,141) (86,533,561)  
Gross Profit. 108,101,235 84,666,083 76,588,046  
Research and development expenses. (3,190,439) (3,208,904) (2,689,468)  
Selling, general and administrative (59,057,350) (37,500,952) (36,103,289)  
Share of profit or loss of joint ventures and associates 611,989 481,442 1,960,549  
Other income 113,378 507,246 (380,871)  
Operating profit 46,578,813 44,944,915 39,374,967  
Financial results (12,668,145) (11,032,748) (30,014,131)  
Profit before income tax 33,910,668 33,912,167 9,360,836  
Income tax expense (16,788,853) (14,141,515) (3,830,106)  
Result for the year 17,121,815 19,770,652 5,530,730  
Foreign exchange differences on translation of foreign operations 1,824,666 1,704,590 1,281,974  
Revaluation of property, plant and equipment, net of tax 2 (5,308,610) (2,682,457) 3,921,091  
Total comprehensive profit (loss) $ 13,637,871 $ 18,792,785 $ 10,733,795  
Insumos Agroqumicos S.A.("Insuagro")        
Summarized financial information        
Proportion of ownership interests held by non-controlling interests 38.68% 49.90%    
Financial position        
Current assets $ 40,361,614 $ 23,293,521    
Non-current assets 2,295,965 2,907,928    
Total assets. 42,657,579 26,201,449    
Current liabilities 35,464,893 20,297,799    
Non-current liabilities 118,460 1,341,613    
Total liabilities. 35,583,353 21,639,412    
Total equity 7,074,226 4,562,037    
Total liabilities and equity 42,657,579 26,201,449    
Summary statements of comprehensive income or loss        
Revenues 49,116,626 7,600,041    
Cost of sales (35,181,813) (5,886,326)    
Gross Profit. 13,934,813 1,713,715    
Selling, general and administrative (7,894,444) (1,065,147)    
Other income 159,794 18,305    
Operating profit 6,200,163 666,873    
Financial results (2,954,581) (961,635)    
Profit before income tax 3,245,582 (294,762)    
Income tax expense (1,421,973) 127,876    
Result for the year 1,823,609 (166,886)    
Foreign exchange differences on translation of foreign operations 733,029 180,519    
Total comprehensive profit (loss) $ 2,556,638 $ 13,633    
[1] The tax effect of the revaluation of property, plant and equipment was $2,837,650, ($1,389,643) and ($1,133,230) for the years ended June 30, 2022, 2021 and 2020, respectively.